Delivery Order SPE2DB20D2104-SPE2DB25FMNHM

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price of $1,455.28 and a period of performance through April 30, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $10,599.22 and a performance period extending through May 2, 2025. The contract is not designated as a set-aside and was awarded on a firm fixed-price basis....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $9,108.56 and a period of performance through April 3, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a prescription medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $4,549.83 and a completion date of September 14, 2023. This contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Januvia 100 mg tablets, a medication used to manage diabetes. The contract has a ceiling value of $3,274.38 and runs through March 27, 2025. It is a firm-fixed-price contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $1,273.37 and a period of performance through April 17, 2025. This contract is not a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $2,264.76 and a period of performance through April 24, 2025. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $4,712.36 and a period of performance through April 23, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition....
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $5,357.22 and a period of performance through May 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,134.52, is for the supply of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of November 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMNHM
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price, with a ceiling value of $1,311.54, and a period of performance ending on April 14, 2025. This contract is not associated with a set-aside program and is an open competition award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/11/25, 10:18 AM